title: Immunosuppressive therapy using CsA, MZ, steroids, and DSG during the early phase after kidney grafting, with later steroid withdrawal.
authors.affiliation: National Children's Medical Research Center, Tokyo, Japan.
authors.forename: S
authors.initials: S
authors.lastname: Suzuki
authors.forename: R
authors.initials: R
authors.lastname: Hayashi
authors.forename: T
authors.initials: T
authors.lastname: Nakatani
authors.forename: H
authors.initials: H
authors.lastname: Amemiya
mesh_terms: D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000008:administration & dosage / Q000627:therapeutic use; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006146:Guanidines / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D011239:Prednisolone / Q000008:administration & dosage / Q000627:therapeutic use; D012263:Ribonucleosides / Q000008:administration & dosage / Q000627:therapeutic use; D013997:Time Factors
chemical_list: D006146:Guanidines; D007166:Immunosuppressive Agents; D012263:Ribonucleosides; C010052:mizoribine; D016572:Cyclosporine; D011239:Prednisolone; D003404:Creatinine; C037258:gusperimus